featured

featured Articles

J.D. Power has released its 2020 U.S. Vehicle Dependability Study. Jaguar and Land Rover were at the bottom of the list.
Crude oil prices have fallen since the outbreak of coronavirus in China was revealed in early January. Short sellers have been selective with their bets and continue to be so.
As of the most recently reported period, short sellers favored Pfizer, Microsoft and Intel above all other Dow stocks.
These so-called sin stocks look like outstanding values and should hold up reasonably well even in a protracted bear market.
The FTC has asked five large technology firms to provide information about prior acquisitions that were not reported to the antitrust agencies under the Hart-Scott-Rodino Act.
Boeing's orders and deliveries showed that the company took in no new net plane orders for the month of January.
CVS Health has faced strong headwinds since last year’s acquisition of health insurer Aetna, but its upcoming earnings report could prove to be a turning point.
Lyft is scheduled to release its most recent quarterly results after the markets close on Tuesday. Rival Uber posted stellar results last week.
Hasbro reported mixed fourth-quarter financial results before the markets opened on Monday. Demand for Disney toys helped boost the results.
It appears that the odds of Sprint becoming part of T-Mobile have improved, and it shows in shares of many rivals, partners and equipment suppliers.
Under Armour released surprising fourth-quarter financial results before the markets opened on Tuesday, prompting a sell-off of its shares.
24/7 Wall St. screened the Merrill Lynch health care research database looking for large pharmaceutical leaders that also pay solid and dependable dividends. These five make sense for growth and...
The coronavirus has taken another victim. Smartphone shipments from China are expected to drop sharply this quarter.
Slack Technologies Inc. (NYSE: WORK) has been in need of some good news for some time. Its shares have not held up since its direct IPO listing in 2019, in most part due to concerns that Microsoft...
Moderna Inc. (NASDAQ: MRNA) had been the biggest biotech initial public offering ever. The company was quite unlucky in the timing for its IPO, but it managed to get back into favor with investors....